Modulation of oncogenic transcription factors by bioactive natural products in breast cancer

M Hasanpourghadi, AK Pandurangan… - Pharmacological …, 2018 - Elsevier
Carcinogenesis, a multi-step phenomenon, characterized by alterations at genetic level and
affecting the main intracellular pathways controlling cell growth and development. There are …

Quantitative modeling of chronic myeloid leukemia: insights from radiobiology

T Radivoyevitch, L Hlatky, J Landaw… - Blood, The Journal of …, 2012 - ashpublications.org
Mathematical models of chronic myeloid leukemia (CML) cell population dynamics are
being developed to improve CML understanding and treatment. We review such models in …

[HTML][HTML] Modelling c-Abl signalling in activated neutrophils: the anti-inflammatory effect of seliciclib

RC Jackson, T Radivoyevitch - Biodiscovery, 2013 - ncbi.nlm.nih.gov
When mammalian tissues are infected by bacteria or fungi, inflammatory cytokines are
released that cause circulating neutrophils to invade the infected tissue. The cytosolic …

Translational regulation by the p210 BCR/ABL oncoprotein

D Perrotti, B Calabretta - Oncogene, 2004 - nature.com
The ability of oncogenic proteins to regulate the rate of translation of specific mRNA subsets
may be a rapid and efficient mechanism to modulate the levels and, in many cases, the …

A multicellular basis for the origination of blast crisis in chronic myeloid leukemia

RK Sachs, K Johnsson, P Hahnfeldt, J Luo, A Chen… - Cancer research, 2011 - AACR
Chronic myeloid leukemia (CML) is characterized by a specific chromosome translocation,
and its pathobiology is considered comparatively well understood. Thus, quantitative …

Morpholino Oligo Antisense efficiently suppresses BCR/ABL and cell proliferation in CML: specific inhibition of BCR-ABL gene expression by Morpholino Oligo …

M Haririan, S Kaviani, M Soleimani, SR Ghaemi… - …, 2012 - Taylor & Francis
Chronic myeloid leukemia is a disorder that develops when a hematopoietic stem cell
acquires the Philadelphia chromosome carrying the chimeric BCR/ABL oncogene leading to …

Evolutionary dynamics of chronic myeloid leukemia progression: the progression-inhibitory effect of imatinib

RC Jackson, T Radivoyevitch - The AAPS journal, 2016 - Springer
Abstract The t (9; 22) translocation that causes chronic myeloid leukemia (CML) drives both
transformation and the progression process that eventually results in the disease changing …

Chronic Myeloid Leukaemia: A One-Hit Malignancy

RC Jackson - Evolutionary Dynamics of Malignancy: The Genetic and …, 2023 - Springer
Chronic myeloid leukaemia (CML) is caused by the Bcr-Abl translocation. It is otherwise
genetically normal. CML is unusual in being a “single-hit” malignancy, ie although other …

[PDF][PDF] БІЛОК BCR ЯК ПАРТНЕР КОМПОНЕНТІВ ЦИТОСКЕЛЕТА ТА ВЕЗИКУЛЯРНОГО ТРАНСПОРТУ ПРИ BCR/ABL-ПОЗИТИВНІЙ ХРОНІЧНИЙ МІЄЛОЇДНІЙ …

ДС ГУР'ЯНОВ - 2021 - imbg.org.ua
НАЦІОНАЛЬНА АКАДЕМІЯ НАУК УКРАЇНИ ІНСТИТУТ МОЛЕКУЛЯРНОЇ БІОЛОГІЇ ТА Page 1
НАЦІОНАЛЬНА АКАДЕМІЯ НАУК УКРАЇНИ ІНСТИТУТ МОЛЕКУЛЯРНОЇ БІОЛОГІЇ ТА …

TKI resistance in CML cell lines: investigating resistance pathways.

C Tang - 2012 - digital.library.adelaide.edu.au
Chronic myeloid leukaemia (CML) is characterised by the presence of the Philadelphia
chromosome which harbours the Bcr-Abl oncogene. BCR-ABL is a constitutively active …